Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies-Reference-Cited by-同舟云学术

Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies

Published:2022-11 Issue:11 Volume:22 Page:1538-1540
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Sheward Daniel J,Kim Changil,Fischbach Julian,Sato Kenta,Muschiol Sandra,Ehling Roy A,Björkström Niklas K,Hedestam Gunilla B Karlsson,Reddy Sai T,Albert Jan,Peacock Thomas P,Murrell Ben

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference7 articles.

1. Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75;Cao;Cell Host Microbe,2022

2. Evasion of neutralising antibodies by omicron sublineage BA.2.75;Sheward;Lancet Infect Dis,2022

3. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection;Cao;Nature,2022

4. Characterization of the SARS-CoV-2 B.1.621 (Mu) variant;Halfmann;Sci Transl Med,2022

5. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization;Cele;Nature,2021

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Higher Omicron JN.1 Coronavirus Transmission due to Unique 17MPLF Spike Insertion compensating 24LPP, 69HV, 145Y, 211N and 483V deletions in the spike;2024-01-04

2. Tracking SARS-CoV-2 variants during the 2023 flu season and beyond in Lebanon;Virus Research;2024-01

3. Russia's attacks on civilians strengthen Ukrainian resistance;PNAS Nexus;2023-12-01

4. Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children;Nature Communications;2023-12-01

5. A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery;PNAS Nexus;2023-11-28